| Symbol | NMLSF |
|---|---|
| Name | RESTART LIFE SCIENCES CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V6C 0A6 Canada BC 700-838 W Hastings Street |
| Telephone | +1 778-819-0244 |
| Fax | — |
| — | |
| Website | https://restartlife.co/ |
| Incorporation | CA |
| Incorporated On | 2004 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Smythe LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | 0001689231 |
| Description | Restart Life Sciences Corp. is a Canadian-based biotechnology company and global leader in psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. Their mission is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder and fragile X syndrome. Additional info from OTC: |
No news found.